Rchr
J-GLOBAL ID：201701015334641234
Update date: Oct. 02, 2024
HASHIMOTO KOSUKE
ハシモト コウスケ | HASHIMOTO KOSUKE
Affiliation and department：
Job title：
Assistant Professor
Research theme for competitive and other funds (2)：
- 2022 - Investigation of deep learning by 18F-FDG PET to search for new biomarkers for immune checkpoint inhibitors in advanced non-small cell lung cancer
- 2020 - 2021 免疫チェックポイント阻害薬の適切な投与間隔・期間、有害事象回避のアルゴリズム開発
Papers (26)：
-
Atsuto Mouri, Kyoichi Kaira, Ou Yamaguchi, Kosuke Hashimoto, Yu Miura, Ayako Shiono, Tomonori Kawasaki, Kunihiko Kobayashi, Hisao Imai & Hiroshi Kagamu. Clinical significance of antinuclear antibody as prognostic marker for first-line pembrolizumab in advanced non-small cell lung cancer. International Journal of Clinical Oncology. 2023. 29. 124-133
-
Kyoichi Kaira, Hisao Imai, Atsuto Mouri, Kosuke Hashimoto, Yu Miura, Ayako Shiono, Ou Yamaguchi, Kunihiko Kobayashi, Tomonori Kawasaki, Masanori Yasuda, et al. Clinicopathological impact of VEGFR2 and VEGF-C in patients with EGFR-major mutant NSCLC receiving osimertinib. Thoracic cancer. 2023. 14. 29. 2950-2961
-
Ou Yamaguchi; Kyoichi Kaira; Hisao Imai; Atsuto Mouri; Ayako Shiono; Yu Miura; Kosuke Hashimoto; Kunihiko Kobayashi; Hiroshi Kagamu. Clinical Utility of Inflammatory and Nutritious Index as Therapeutic Prediction of Nivolumab plus Ipilimumab in Advanced Non-Small Cell Lung Cancer. Oncology. 2023. 102. 3. 271-282
-
橋本 康佑, 解良恭一. 呼吸器領域での免疫チェックポイント阻害薬の歴史とエビデンス. 日本気管食道科学会会報. 2022. 73. 5
-
Imai H, Naito E, Yamaguchi O, Hashimoto K, Iemura H, Miura Y, Shiono A, Mouri A, Kaira K, Kobayashi K, et al. Pretreatment body mass index predicts survival among patients administered nivolumab monotherapy for pretreated non-small cell lung cancer. Thorac Cancer. 2022. 13. 10. 1479-1489
ｍore...
Lectures and oral presentations (6)：
-
進展型小細胞肺癌に対する抗PD-L1抗体を含む併用化学療法における予後予測因子としてのFDG-PETの有用性
(第63回 日本呼吸器学会学術集会 2023)
-
進行期非小細胞肺癌に対するPD-1/PD-L1阻害剤+細胞障害性抗がん剤併用療法における18F-FDG集積の予後解析
(第63回 日本肺癌学会 2022)
-
抗PD-1抗体治療後の腫瘍内 18F-FDG集積の視覚的評価による予後解析
(第62回 日本肺癌学会学術集会 2021)
-
PD-L1発現 50%以上の非小細胞肺癌初回治療におけるペンブロリズマブ単剤の予後予測としてのFDG-PETの意義
(第61回日本呼吸器学会学術講演会 2021)
-
Role of FDG uptake as predictivie marker of PD-1 inhibitor in patients with previously non-small cell lung cancer
(2020)
ｍore...
Education (1)：
- 2015 - 2021 Saitama Medical University Graduate School, Division of Medicine
Professional career (1)：
Return to Previous Page
